Retention of heroin and morphine-6β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1

被引:254
作者
Schuller, AGP
King, MA
Zhang, JW
Bolan, E
Pan, YX
Morgan, DJ
Chang, A
Czick, ME
Unterwald, EM
Pasternak, GW
Pintar, JE
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, CABM, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA
[2] Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, New York, NY 10021 USA
[3] NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA
关键词
D O I
10.1038/5706
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Morphine produces analgesia by activating mu opioid receptors encoded by the MOR-1 gene. Although morphine-6 beta-glucuronide (M6G), heroin and 6-acetylmorphine also are considered mu opioids, recent evidence suggests that they act through a distinct receptor mechanism. We examined this question in knockout mice containing disruptions of either the first or second coding exon of MOR-1. Mice homozygous for either MOR-1 mutation were insensitive to morphine. Heroin, 6-acetylmorphine and M6G still elicited analgesia in the exon-l MOR-1 mutant, which also showed specific M6G binding, whereas M6G and 6-acetylmorphine were inactive in the exon-2 MOR-1 mutant. These results provide genetic evidence for a unique receptor site for M6G and heroin analgesia.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 30 条
[1]   EXPRESSION OF 2 VARIANTS OF THE HUMAN MU-OPIOID RECEPTOR MESSENGER-RNA IN SK-N-SH CELLS AND HUMAN BRAIN [J].
BARE, LA ;
MANSSON, E ;
YANG, DM .
FEBS LETTERS, 1994, 354 (02) :213-216
[2]   Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha 1-syntrophin mediated by PDZ domains [J].
Brenman, JE ;
Chao, DS ;
Gee, SH ;
McGee, AW ;
Craven, SE ;
Santillano, DR ;
Wu, ZQ ;
Huang, F ;
Xia, HH ;
Peters, MF ;
Froehner, SC ;
Bredt, DS .
CELL, 1996, 84 (05) :757-767
[3]  
Brown GP, 1997, J PHARMACOL EXP THER, V282, P1291
[4]   3-Methoxynaltrexone, a selective heroin/morphine-6 beta-glucuronide antagonist [J].
Brown, GP ;
Yang, K ;
King, MA ;
Rossi, GC ;
Leventhal, L ;
Chang, A ;
Pasternak, GW .
FEBS LETTERS, 1997, 412 (01) :35-38
[5]   AN ANTISENSE OLIGODEOXYNUCLEOTIDE TO MU-OPIOID RECEPTORS INHIBITS MU-OPIOID RECEPTOR AGONIST-INDUCED ANALGESIA IN RATS [J].
CHEN, XH ;
ADAMS, JU ;
GELLER, EB ;
DERIEL, JK ;
ADLER, MW ;
LIUCHEN, LY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 275 (01) :105-108
[6]   TARGETED DISRUPTION OF THE NEURONAL NITRIC-OXIDE SYNTHASE GENE [J].
HUANG, PL ;
DAWSON, TM ;
BREDT, DS ;
SNYDER, SH ;
FISHMAN, MC .
CELL, 1993, 75 (07) :1273-1286
[7]   THE PHARMACOKINETICS OF HEROIN IN PATIENTS WITH CHRONIC PAIN [J].
INTURRISI, CE ;
MAX, MB ;
FOLEY, KM ;
SCHULTZ, M ;
SHIN, SU ;
HOUDE, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (19) :1213-1217
[8]   EVIDENCE FROM OPIATE BINDING-STUDIES THAT HEROIN ACTS THROUGH ITS METABOLITES [J].
INTURRISI, CE ;
SCHULTZ, M ;
SHIN, S ;
UMANS, JG ;
ANGEL, L ;
SIMON, EJ .
LIFE SCIENCES, 1983, 33 :773-776
[9]  
Joyner AL, 1993, GENE TARGETING PRACT, P234, DOI DOI 10.1093/OSO/9780199637928.001.0001
[10]   μ opioid receptor knockout in mice:: effects on ligand-induced analgesia and morphine lethality [J].
Loh, HH ;
Liu, HC ;
Cavalli, A ;
Yang, WL ;
Chen, YF ;
Wei, LN .
MOLECULAR BRAIN RESEARCH, 1998, 54 (02) :321-326